Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials

John Mascarenhas, Ruben Mesa, Josef Prchal, Ronald Hoffman

Research output: Contribution to journal › Editorial › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials'. Together they form a unique fingerprint.